肝细胞癌(HCC)是世界上一些地区最常见的恶性肿瘤之一,预后极差。肝细胞癌发生的分子机制核心足多种基因突变和遗传不稳定,这些情况大多数来自慢性肝脏病及相关的肝细胞再生及有丝分裂活性增强。 HCC 的基因治疗可分为三类:基因替代或修复,基因增强,DNA 疫苗。由于肝细胞肿瘤发生的遗传改 Hepatocellular carcinoma (HCC) is one of the most common malignancies in some parts of the world and has a very poor prognosis. The molecular mechanism of hepatocellular carcinoma occurs in a variety of gene mutations and genetic instability, most of which come from chronic liver disease and related hepatocyte regeneration and mitotic activity. HCC gene therapy can be divided into three categories: gene replacement or repair, gene enhancement, DNA vaccine. Hepatocellular carcinoma due to genetic changes